Bold headline: The Diamondbacks and Zac Gallen are back in the fold, but under a practical one-year deal that reflects a complex market and a surprising performance year.
But here’s where it gets interesting: the contract is one year, with the signing still awaiting a routine physical. The latest reports indicate the Diamondbacks are nearing a deal to bring Gallen back, even after he spent a stretch on the open market following his decision to decline the qualifying offer earlier this offseason.
Gallen, a right-hander who long looked like a standout free-agent target capable of commanding well over $100 million, faced a quieter market this winter. He did stay healthy and made all 33 of his planned starts, but his traditional statistics showed the weakest marks of his career. He posted a personal-best workload in terms of innings pitched, yet his ERA rose to 4.83, and his strikeout rate dropped to 21.5%—the lowest in his career.
What this means going forward is nuanced. A one-year arrangement can give both sides flexibility: the Diamondbacks can reassess Gallen’s value after a full health season, and he can demonstrate resurgence and build leverage for 2027. For fans, it signals a renewed pairing between club and pitcher that could become a cornerstone if Gallen rebounds.
Additional updates are expected as the deal progresses through the medical review and the official terms are finalized.
What do you think about one-year deals for proven stars after down seasons? Do you believe this approach maximizes upside or risks future stability? Share your thoughts in the comments.
